Related references
Note: Only part of the references are listed.Communicating THC levels and 'dose' to consumers: Implications for product labelling and packaging of cannabis products in regulated markets
David Hammond
INTERNATIONAL JOURNAL OF DRUG POLICY (2021)
New trends in cannabis potency in USA and Europe during the last decade (2008-2017)
Suman Chandra et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
Thomas R. Arkell et al.
PSYCHOPHARMACOLOGY (2019)
CLINICAL UPDATE Medicinal use of cannabis based products and cannabinoids
Tom P. Freeman et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Changes in the Composition of Cannabis From 2000-2017 in Denmark: Analysis of Confiscated Samples of Cannabis Resin
Kristine Romer Thomsen et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2019)
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
Abigail M. Freeman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Increasing potency and price of cannabis in Europe, 2006-16
Tom P. Freeman et al.
ADDICTION (2019)
Higher average potency across the United States is associated with progression to first cannabis use disorder symptom
Brooke J. Arterberry et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
Nadia Solowij et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
The neuropsychopharmacology of cannabis: A review of human imaging studies
Michael A. P. Bloomfield et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2019)
The impacts of potency, warning messages, and price on preferences for Cannabis flower products
Yuyan Shi et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2019)
Changing landscape of cannabis: novel products, formulations, and methods of administration
Tory R. Spindle et al.
CURRENT OPINION IN PSYCHOLOGY (2019)
Cannabis Dampens the Effects of Music in Brain Regions Sensitive to Reward and Emotion
Tom P. Freeman et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Cannabis use and risk of schizophrenia: a Mendelian randomization study
J. Vaucher et al.
MOLECULAR PSYCHIATRY (2018)
Reducing the standard serving size of alcoholic beverages prompts reductions in alcohol consumption
Inge Kersbergen et al.
ADDICTION (2018)
Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial
Rachel L. Tomko et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Potency of Delta(9)-tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology
David J. Potter et al.
DRUG TESTING AND ANALYSIS (2018)
Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands
Tom P. Freeman et al.
PSYCHOLOGICAL MEDICINE (2018)
Quantitative Criteria to Screen for Cannabis Use Disorder
Cristina Casajuana et al.
EUROPEAN ADDICTION RESEARCH (2018)
Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods
Krista M. Lisdahl et al.
DEVELOPMENTAL COGNITIVE NEUROSCIENCE (2018)
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia
Joelle A. Pasman et al.
NATURE NEUROSCIENCE (2018)
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
Celia J. A. Morgan et al.
TRANSLATIONAL PSYCHIATRY (2018)
Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis A Crossover Trial
Tory R. Spindle et al.
JAMA NETWORK OPEN (2018)
Big data on a big new market: Insights from Washington State's legal cannabis market
Jonathan P. Caulkins et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2018)
Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study
S. H. Gage et al.
PSYCHOLOGICAL MEDICINE (2017)
A study of cannabis potency in France over a 25 years period (1992-2016)
Laurence Dujourdy et al.
FORENSIC SCIENCE INTERNATIONAL (2017)
Association of State Recreational Marijuana Laws With Adolescent Marijuana Use
Magdalena Cerda et al.
JAMA PEDIATRICS (2017)
Associations between butane hash oil use and cannabis-related problems
Madeline H. Meier
DRUG AND ALCOHOL DEPENDENCE (2017)
Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute Administration
Chandni Hindocha et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Benedikt Fischer et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2017)
The Standard Joint Unit
Cristina Casajuana Kogel et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
How four US states are regulating recreational marijuana edibles
Camille Gourdet et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Consumer use and understanding of labelling information on edible marijuana products sold for recreational use in the states of Colorado and Washington
Katherine M. Kosa et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration
Matthew N. Newmeyer et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial
Amir Englund et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users
Valentina Lorenzetti et al.
BIOLOGICAL PSYCHIATRY (2016)
Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake
Matthew N. Newmeyer et al.
CLINICAL CHEMISTRY (2016)
Keep off the grass? Cannabis, cognition and addiction
H. Valerie Curran et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses
Will Lawn et al.
PSYCHOPHARMACOLOGY (2016)
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Arianna Marconi et al.
SCHIZOPHRENIA BULLETIN (2016)
Unintentional Pediatric Exposures to Marijuana in Colorado, 2009-2015
George Sam Wang et al.
JAMA PEDIATRICS (2016)
Effects of Cannabis Use on Human Behavior: A Call for Standardization of Cannabis Use Metrics
Nadia Solowij et al.
JAMA PSYCHIATRY (2016)
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Nora D. Volkow et al.
JAMA PSYCHIATRY (2016)
Cannabis Use and Risk of Psychiatric Disorders Prospective Evidence From a US National Longitudinal Study
Carlos Blanco et al.
JAMA PSYCHIATRY (2016)
Hippocampal harms, protection and recovery following regular cannabis use
M. Yuecel et al.
TRANSLATIONAL PSYCHIATRY (2016)
Trend of Δ9-THC content of cannabis resin seized in Morocco from 2005 to 2014
Hamid Stambouli et al.
TOXICOLOGIE ANALYTIQUE ET CLINIQUE (2016)
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study
Tabea Schoeler et al.
LANCET PSYCHIATRY (2016)
Gram Years: A Method to Standardize and Quantify Lifetime Cannabis Consumption
Reagan R. Wetherill et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Potency trends of 9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15
Raymond J. M. Niesink et al.
ADDICTION (2015)
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
Chandni Hindocha et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
T. P. Freeman et al.
PSYCHOLOGICAL MEDICINE (2015)
Cannabis potency in the Venice area (Italy): Update 2013
Luca Zamengo et al.
DRUG TESTING AND ANALYSIS (2015)
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2015)
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study
Peggy van der Pol et al.
ADDICTION (2014)
Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
Tom P. Freeman et al.
ADDICTION (2014)
Effects of minimum unit pricing for alcohol on different income and socioeconomic groups: a modelling study
John Holmes et al.
LANCET (2014)
Young adult sequelae of adolescent cannabis use: an integrative analysis
Edmund Silins et al.
LANCET PSYCHIATRY (2014)
Validation of self-reported cannabis dose and potency: an ecological study
Peggy van der Pol et al.
ADDICTION (2013)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
Wendy Swift et al.
PLOS ONE (2013)
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
R. Martin-Santos et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Quantifying cannabis use with the Timeline Followback approach: A psychometric evaluation
Melissa M. Norberg et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
C. J. A. Morgan et al.
PSYCHOLOGICAL MEDICINE (2012)
A postal intervention for dependent cannabis users
Melissa M. Norberg et al.
DRUG AND ALCOHOL REVIEW (2012)
A 'standard joint'? The role of quantity in predicting cannabis-related problems
C. Zeisser et al.
ADDICTION RESEARCH & THEORY (2012)
The 'grass ceiling': limitations in the literature hinder our understanding of cannabis use and its consequences
Elizabeth C. Temple et al.
ADDICTION (2011)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Methods of the Pharmacological Imaging of the Cannabinoid System (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition
Hendrika H. van Hell et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2011)
Pharmacological actions and therapeutic uses of cannabis and cannabinoids
R. N. Kumar et al.
ANAESTHESIA (2010)
Impact of cannabidiol on the acute and psychotomimetic effects of smoked cannabis: naturalistic study
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
Celia J. A. Morgan et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Modelling of the concentration-effect relationship of THC on central nervous system parameters and heart rate - insight into its mechanisms of action and a tool for clinical research and development of cannabinoids
A. Strougo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Blunted psychotomimetic and amnestic effects of Δ-9-tetrahydrocannabinol in frequent users of cannabis
Deepak Cyril D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Theresa H. M. Moore et al.
LANCET (2007)
Opioid antagonism of cannabinoid effects: Differences between marijuana smokers and nonmarijuana smokers
Margaret Haney
NEUROPSYCHOPHARMACOLOGY (2007)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users
HV Curran et al.
PSYCHOPHARMACOLOGY (2002)
Share Paper
